Page 61 - Read Online
P. 61

Lee. Vessel Plus 2022;6:7                                                  Vessel Plus
               DOI: 10.20517/2574-1209.2021.31



               Perspective                                                                   Open Access



               Unique contribution of one patient advocacy

               organization in advancing cerebral cavernous
               malformation awareness and research


               Cornelia Lee

               Angioma Alliance, Charlottesville, Virginia 22901, USA.
               Correspondence to: Dr. Cornelia Lee, Angioma Alliance, 977 Seminole Trail, #367, Charlottesville, Virginia 22901, USA. E-mail:
               clee@angiomaalliance.org
               How to cite this article: Lee C. Unique contribution of one patient advocacy organization in advancing cerebral cavernous
               malformation awareness and research. Vessel Plus 2022;6:7. https://dx.doi.org/10.20517/2574-1209.2021.31
               Received: 19 Feb 2021  First Decision: 17 Mar 2021  Revised: 25 Mar 2021  Accepted: 8 Apr 2021   Published: 17 Feb 2022

               Academic Editor: Jun Zhang  Copy Editor: Yue-Yue Zhang  Production Editor: Yue-Yue Zhang

               Abstract
               Advocacy organizations have long played a role in advancing care and research for patients affected by rare
               disease. Angioma Alliance has served traditional functions of organizing scientific meetings and creating shared
               resources like a tissue bank and a patient registry. Uniquely, the organization has employed creative patient
               engagement methods like subsidized genetic testing as well as targeting special populations to expand research
               participation and understanding of the illness. Special populations include those with CCM3 mutations, the CCM1
               Common Hispanic Mutation, and Black patients.

               Keywords: Cavernous, angioma, malformation, cavernoma, advocacy, cerebrovascular disorders, patient cohorts,
               patient community, Hispanic, founder mutation



               INTRODUCTION
               Angioma Alliance was founded in 2002 to serve the cerebral cavernous malformation (CCM) patient and
               research community. Over the course of the past 18 years, the organization has grown from a mother’s
               kitchen table to an international partner in the work toward better treatments. The organization does not
               fund research directly; rather the focus is on creating shared resources for researchers and for patients with
               a special focus on expanding, engaging, and characterizing the patient base.







                           © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                             www.vpjournal.net
   56   57   58   59   60   61   62   63   64   65   66